awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33394153-2B395809-564F-4AA4-B2DD-9236F9790F43
Q33394153-2B395809-564F-4AA4-B2DD-9236F9790F43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394153-2B395809-564F-4AA4-B2DD-9236F9790F43
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).
P2860
Q33394153-2B395809-564F-4AA4-B2DD-9236F9790F43
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394153-2B395809-564F-4AA4-B2DD-9236F9790F43
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68acffe35bcf962b2067a0c5aab2db9eafc06d79
P2860
Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.